COVIP study

Corona Virus disease (COVID19) in Very Elderly Intensive care Patients (VIPs)

Please see the COVIP page for information and registration.

324 ICUs
(Updated: 24-11-2020 20:13)
43 countries
(Updated: 24-11-2020 20:13)
2107 patients
(Updated: 24-11-2020 20:13)

See the
COVIP study
information page

The COVIP study is a multinational, multicenter study of outcomes and prognostic factors in coronavirus disease (COVID-19) in very old intensive care patients. See the COVIP page for information, registration, country coordinator list, protocol, documents, notes and ethical approval etc.

The COVIP study has two recruitment parts. Part 1 (March to May 26th) has finished and part 2 (September 1st to December 31st 2020) is ongoing. You can still register your ICU and participate until the end of the year. ICUs that have recruited patients in period 1 are encouraged to continue recruiting patients until the end of the year. We thank everyone for their efforts!

The COVIP study is endorsed by ESICM (European Society of Intensive Care Medicine)

VIP1 and VIP2 studies

The VIP1 and VIP2 studes were international, multicenter studies of the old intensive care unit population. There are among the largest prospective studies conducted in the elderly intensive care population. The data from VIP2 is currently being analyzed and published.